Artax Biopharma, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States
Artax Biopharma, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $19 million sold in a notice filed in 2026.
Artax Biopharma at a glance
What does Artax Biopharma do?
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $19 million sold (2026).
Frequently asked questions about Artax Biopharma
Where is Artax Biopharma headquartered?
Artax Biopharma, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Artax Biopharma do?
Artax Biopharma, Inc. is a pharmaceutical company.
When was Artax Biopharma founded?
The earliest incorporation on record for Artax Biopharma, Inc. is in 2013, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences